Encenicline (EVP-6124)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Encenicline (EVP-6124), covering 2016-05-03 to 2016-05-03. Get the full timeline:
Most recent: Clinical Trial Update: A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy [Phase 3]